Find similar content

Source channel @githubtrending · Post #15074 · Aug 19

#vue#javascript#music#music_library#music_player#musicplayer#pinia#splayer#vite#vue#vue3 SPlayer is a simple, open-source music player designed mainly for Windows, built with modern web technologies like Vue 3 and Electron. It supports features like login via QR code or phone, daily check-ins, desktop lyrics, local music management, playlist creation, cloud music upload and playback, and even plays some songs without copyright restrictions. It offers light/dark themes, music spectrum visualization, and supports high-quality downloads if you have the right membership. You can deploy it locally or on servers using Docker or Vercel. This player is free for personal use and encourages community contributions, helping you enjoy and organize music easily with a customizable, modern interface. https://github.com/imsyy/SPlayer

Hashtags

#vue #javascript #music #music_library #music_player #musicplayer #pinia #splayer #vite #vue3

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment